Abstract:Protein inclusions containing phosphorylated TDP-43 are a shared pathology in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, most ALS/FTD patients do not have a mutation in TDP-43 or the enzymes directly regulating its phosphorylation. It is intriguing how TDP-43 becomes hyperphosphorylated in each disease condition. In a genetic screen for novel TDP-43 modifiers, we found that knockdown (KD) of CHMP2B , a key component of the endosomal sorting complex required for transport (ESCRT) machinery, suppressed TDP-43-mediated neurodegeneration in Drosophila . Further investigation using mammalian cells indicated that CHMP2B KD decreased whereas its overexpression (OE) increased TDP-43 phosphorylation levels. Moreover, a known FTD-causing mutation CHMP2B intron5 promoted hyperphosphorylation, insolubility and cytoplasmic accumulation of TDP-43. Interestingly, CHMP2B did not manifest these effects by its well-known function in the autophagy-lysosomal pathway. Instead, the kinase CK1 tightly regulated TDP-43 phosphorylation level in cells, and CHMP2B OE or CHMP2BIntron5 significantly decreased ubiquitination and the turnover of CK1 via the ubiquitin-proteasome (UPS) pathway. Finally, we showed that CHMP2B protein levels increased in the cerebral cortices of aged mice, which might underlie the age-associated TDP-43 pathology and disease onset. Together, our findings reveal a molecular link between the two ALS/FTD-pathogenic proteins CHMP2B and TDP-43, and provide an autophagy-independent mechanism for CHMP2B in pathogenesis. SIGNIFICANCE STATEMENT TDP-43 and CHMP2B are both ALS/FTD-associated proteins. Protein aggregations containing phosphorylated TDP-43 are a pathological hallmark of ALS/FTD; however, it is unclear how increased phosphorylation of TDP-43 occurs in diseases. The pathogenesis of CHMP2B has mainly been considered as a consequence of autophagy-lysosomal dysfunction. Here, we reveal that increase of CHMP2B levels (which occurs in aged mouse brains) or expression of the disease-causing mutation CHMP2BIntron5 promotes TDP-43 hyperphosphorylation, insolubility and cytoplasmic mislocalization. This effect is independent of the autophagy-lysosomal pathway but rather relies on the proteasome-mediated turnover of the kinase CK1 that phosphorylates TDP-43. Together, we provide a new molecular mechanism of CHMP2B pathogenesis by linking it to TDP-43 pathology via CK1. ### Competing Interest Statement The authors have declared no competing interest.

Modulation of Synaptic Plasticity, Motor Unit Physiology, and TDP-43 Pathology by CHCHD10.

CHCHD10 MUTATIONS SYNERGIZE WITH TDP-43 TO PROMOTE NEURONAL APOPTOSIS

CHCHD10-regulated OPA1-mitofilin Complex Mediates TDP-43-induced Mitochondrial Phenotypes Associated with Frontotemporal Dementia.

P4‐090: Chchd10 Mutations Synergize with TDP‐43 to Promote Neuronal Apoptosis

Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion

Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases

Neuropathologic Description of CHCHD10 Mutated Amyotrophic Lateral Sclerosis

Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation

CHCHD10S59L/+ mouse model: Behavioral and neuropathological features of frontotemporal dementia

Amyloid fibril structures link CHCHD10 and CHCHD2 to neurodegeneration.

CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response

Mutation analysis of CHCHD10 in different neurodegenerative diseases.

The CHCHD2-CHCHD10 protein complex is modulated by mitochondrial dysfunction and alters lipid homeostasis in the mouse brain.

CHCHD2 and CHCHD10: Future Therapeutic Targets in Cognitive Disorder and Motor Neuron Disorder

CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis

Evaluation of Mitochondrial Function in CHCHD10 Mutation (P5.001)

CHMP2B Regulates TDP-43 Phosphorylation and Proteotoxicity Via Modulating CK1 Turnover Independent of the Autophagy-Lysosomal Pathway

Frontotemporal Dementia-Related V57E Mutation Impairs Mitochondrial Function and Alters the Structural Properties of CHCHD10

Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology

CHCHD10 Mutations in Patients with Amyotrophic Lateral Sclerosis in Mainland China.